To our knowledge, the present study is the first to identify the epigenetic control of GABPB1, highlighting how cancer-associated DNA methylation downregulates GABPB1 to decrease its tumor-suppressing functions during TC development. This evidence concerns the gene GABPB1 and neoplasm.